OncLive

Education ▼

Register | Login

Conference Coverage

Attend An Event

State of the Science Summit

Regional Seminar Series

PER Conferences

Giants of Cancer Care

OncLive Community

SPECIALTY TOPICS

CURRENTLY VIEWING
All Specialties

Multiple Myeloma

Immuno-Oncology News

Gynecologic Oncology

Gastrointestinal Cancer

Colorectal Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

OncLive TV: Charles A. Leath III, MD

<< Back to Our Featured Experts

Dr. Leath on Agents Under Investigation in Cervical Cancer

Dr. Leath on Agents Under Investigation in Cervical Cancer

Dr. Leath on the Results of the GOG 240 Trial in Advanced Cervical Cancer

Dr. Leath on the Results of the GOG 240 Trial in Advanced Cervical Cancer

Dr. Leath on Challenges With Bevacizumab in Cervical Cancer

Dr. Leath on Challenges With Bevacizumab in Cervical Cancer

Oncology Specialists

ABCDEFGHIJKLMNOPQRSTUVWXYZ

John V.Heymach, MD, PhD

Daniel Vaena, MD

Linda T. Vahdat, MD

Cesar Rodriguez Valdes, MD

Frances Valdes-Albini, MD

Jason Valent, MD

Eric Vallieres, MD

Vincent Vandecaveye, MD, PhD

Ari VanderWalde, MD

Carlos E. Vargas, MD

Laura van 't Veer, PhD

Vamsidhar Velcheti, MD

Peter J. Van Veldhuizen, MD

Alan P. Venook, MD

Sunil Verma, MD

Udit Verma, MD

Sunil Verma, MD, MSEd, FRCPC

Claire Verschraegen, MD

Srdan Verstovsek, MD, PhD

Frank A. Vicini, MD

Andrew Vickers, PhD

Gregory Vidal, MD, PhD

Ravi Vij, MD

Ravi Vij, MD, MBA

Victoria Villaflor, MD

Victoria M. Villaflor, MD

Augusto Villanueva, MD, PhD

Liza C. Villaruz, MD

Katherine Virgo, PhD

Guiseppe Visani, MD

Rogerio Vivaldi, MD

Daniel R. Vlock, MD

Nicholas J. Vogelzang, MD

Everett Vokes, MD

Everett E. Vokes, MD

Peter Voorhees, MD

Martin H. Voss, MD

Martin H. Voss, MD,

OncLive SAP

Evolving HCC Treatment Paradigm: Combinations and Sequencing

Trending Now

Patient Factors Critical to Treatment Selection in Prostate Cancer, RCC

Thriving Therapeutics Transform Relapsed/Refractory Myeloma Paradigm

New BTK Agents and Combinations Are on the Horizon for B-cell Malignancies

Olaparib Approved in China for Frontline Maintenance in Ovarian Cancer

Covering Every Angle of Oncology Practice. Click a cover below, to view more.

Publication Bottom Border

Priority Report

Dermatologists in Cancer Care®

Pulmonologists in Cancer Care

Rapid Reporter®

Milestones In Medicine

Rapid Reviews in Oncology®

Urologists in Cancer Care

Oncology Business News

Contemporary Radiation Oncology

Oncology Nursing News

Oncology Fellows

Precision Medicine in Oncology

Invited Presentations

Oncology Treatment Pathways®

CURE Rare Cancers-Summer 2017 Issue

HEAL Summer 2017

Extraordinary Healers Vol. 11

Border Publication

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Oncology Nursing News
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc

OncLive Resources

Articles
Blogs
Conference Coverage
OncLive TV
Peer Exchange
Publications
Specialties
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Forgot Password
Press Releases
Privacy Policy
Terms & Conditions

iTunes

YouTube

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-939-0221

Copyright OncLive 2006-2019
Intellisphere, LLC. All Rights Reserved.

x